Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Portopulmonary hypertension.

Michael Passarella1, Michael B Fallon, Steven M Kawut

  • 1Department of Medicine, University of Alabama at Birmingham, BDB 327, 1530 3rd Avenue S., Birmingham, AL 35294, USA.

Clinics in Liver Disease
|December 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Association Between Pulmonary Hypertension, End-Stage Kidney Disease, and Death: An Analysis of the Chronic Renal Insufficiency Cohort Study (CRIC).

Kidney medicine·2026
Same author

Surrogate Endpoints are Risky Business in Pulmonary Arterial Hypertension.

American journal of respiratory and critical care medicine·2026
Same author

Racial Disparities in Clinical and Cardiometabolic Outcomes Among Patients with Alcohol-Associated Liver Disease.

Digestive diseases and sciences·2026
Same author

Alveolar Type 2 Cell Dysfunction Is Associated with Bile Acid Alterations in Experimental Hepatopulmonary Syndrome.

American journal of respiratory cell and molecular biology·2026
Same author

The Importance of Liver-Lung Communication in Pulmonary Vascular Diseases.

Comprehensive Physiology·2026
Same author

Disparities in Liver Transplantation Among Native Americans and Hispanic Individuals: Insights from a Southwest Region Center in the United States of America.

Journal of clinical medicine·2026
Same journal

Metabolic Dysfunction-Associated Steatohepatitis: From Fibrosis-Based Risk Stratification to Emerging Therapeutic Strategies.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management.

Clinics in liver disease·2026
See all related articles

Portopulmonary hypertension, a complication of portal hypertension, presents unique diagnostic and therapeutic challenges. This review covers its pathophysiology, diagnosis, emerging treatments, and liver transplant safety.

Area of Science:

  • Cardiology
  • Hepatology
  • Pulmonary Medicine

Background:

  • Portopulmonary hypertension (POPH) frequently complicates portal hypertension.
  • Understanding POPH is crucial for managing patients with liver disease.

Purpose of the Study:

  • To review the definition, clinical presentation, and pathophysiology of POPH.
  • To outline diagnostic strategies and emerging therapies for POPH.
  • To assess the safety of liver transplantation in POPH patients.

Main Methods:

  • Literature review of existing studies on portopulmonary hypertension.
  • Synthesis of current knowledge on POPH pathophysiology and diagnosis.
  • Evaluation of current and investigational treatment options.
  • Review of outcomes for liver transplantation in POPH patients.

Related Experiment Videos

Main Results:

  • POPH definition and clinical features are established.
  • Pathophysiology involves complex vascular remodeling.
  • Diagnostic criteria and approaches are outlined.
  • Novel therapies are under investigation.
  • Liver transplantation safety in POPH is a critical consideration.

Conclusions:

  • POPH requires a multidisciplinary approach for management.
  • Further research into novel therapies and transplant outcomes is warranted.
  • Accurate diagnosis and timely intervention improve patient outcomes.